Marinus Pharmaceuticals reported $37K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Aptinyx Inc APTX:US USD 677K 0
Biogen BIIB:US USD 100K 0
Esperion Therapeutics ESPR:US USD 72K 7K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Intra Cellular Therapies ITCI:US USD 9K 0
Marinus Pharmaceuticals MRNS:US USD 37K 0
Minerva Neurosciences NERV:US USD 1000 0
Ptc Therapeutics PTCT:US USD 71K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Supernus Pharmaceuticals SUPN:US USD 54K 1000